Rapid-deployment aortic valve replacement in high-risk patients: A case-control study
Open Access
- 30 January 2021
- journal article
- research article
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 13 (1) , 23-27
Abstract
Introduction: Aortic valve stenosis is the most frequent cardiac valve pathology in the western world. In high-risk patients, conventional aortic valve replacement (C-AVR) carries high rates of morbidity and mortality. In the last few years, rapid-deployment valves (RDV) have been developed to reduce the surgical risks. In this work, we aimed to compare the mid-term outcomes of rapid-deployment AVR (RD-AVR) with those of the C-AVR in high-risk patients. Methods: This retrospective case-control study identified 23 high-risk patients who underwent RD-AVR between 12/2015 to 01/2018. The study group was compared with a control group of 46 patients who were retrospectively selected from a database of 687 C-AVR patients from 2016 to 2017 which matched with the study group for age and Euro SCORE II. Results: RD-AVR group presented more cardiovascular risk factors. Euro SCORE II was higher in the RD-AVR group (P=0.06). In the RD-AVR group, we observed significantly higher mean prosthetic size (P<0.001). In-hospital mortality was zero in RD-AVR group versus 2 deaths in C-AVR group. Hospital stay was longer in the RD-AVR group with statistical significance (P=0.03). In the group AVR with associated cardiac procedures, while comparing subgroups RD-AVR versus C-AVR, early mean gradient was lower in the first cited (P=0.02). The overall mean follow-up was 10.9 ± 4.3 months. Conclusion: The RD-AVR technique is reliable and lead to positive outcomes. This procedure provides a much larger size with certainly better flow through the aortic root. It is an alternative to C-AVR in patients recognized to be surgically fragile.Keywords
This publication has 14 references indexed in Scilit:
- Sutureless aortic bioprosthesisInteractive CardioVascular and Thoracic Surgery, 2017
- Initial Experience with Sutureless Sorin Perceval S Aortic Prosthesis for the Treatment of Prosthetic Valve EndocarditisThe Thoracic and Cardiovascular Surgeon, 2015
- Sutureless Aortic Valve Replacement for Aortic IncompetenceJournal of Cardiac Surgery, 2015
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive SummaryCirculation, 2014
- Comparison between three types of stented pericardial aortic valves (Trivalve trial): study protocol for a randomized controlled trialTrials, 2013
- Sutureless Aortic Valve ImplantationOperative Techniques in Thoracic and Cardiovascular Surgery, 2013
- Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomesThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Evaluation of Operative Risk in Elderly Patients Undergoing Aortic Valve Replacement: The Predictive Value of Operative Risk ScoresCardiology, 2010
- Guidelines for Reporting Mortality and Morbidity After Cardiac Valve InterventionsThe Annals of Thoracic Surgery, 2008
- Aortic CalcificationEuropean Journal of Vascular and Endovascular Surgery, 2005